Back

CanSino Biologics reports over 30% closing-price deviation across three sessions

Verifying
  • CanSino Biologics reported abnormal volatility in its stock trading.
  • The cumulative daily closing-price deviation exceeded 30% over three sessions.
  • The affected trading sessions were Sept. 28, 29 and 30, 2026.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.